Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.33 |
| ▸ | MAOA | P21397 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10286208 | 0.83 | KDM4E (0.37) | MAOBMAOAKMT2AMEN1POLB | |
| SCHEMBL10286115 | 0.79 | ALDH1A1 (0.41) | MAOAKMT2AMEN1 | |
| SCHEMBL10286100 | 0.76 | L3MBTL1 (0.36) | MAOBMAOAKMT2APGK1MEN1 | |
| SCHEMBL10286580 | 0.76 | ALDH1A1 (0.44) | MAOAKMT2AMEN1 | |
| SCHEMBL10286196 | 0.74 | MAOB (0.32) | MAOBMAOAPGK1 | |
| SCHEMBL10286493 | 0.74 | L3MBTL1 (0.36) | MAOBMAOAKMT2APGK1MEN1 | |
| SCHEMBL10286156 | 0.72 | NPC1 (0.34) | MAOBMAOAKMT2AMEN1 | |
| SCHEMBL10286109 | 0.71 | HSD17B1 (0.34) | MAOBMAOA | |
| SCHEMBL10286474 | 0.69 | KDM4E (0.33) | MAOBMAOAKMT2AMEN1 | |
| SCHEMBL10286632 | 0.68 | HSD17B1 (0.37) | MAOBMAOAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130102631-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-25 | — | — | US | disclosed |
| US-20130102631-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-25 | — | — | US | disclosed |
| WO-2012001040-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102631-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | MSR1, DDT, MPO | MAOB 473/4885MAOA 334/4885KMT2A 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.